The purpose of the Mouse Core will be to provide a centralized service-oriented facility to insure the capacity
of each participating project to produce and maintain transgenic and gene-disrupted mice. The mouse core
will also serve the projects of this Program by supporting the infrastructure of the BUXCO system for making
invasive resistance and compliance measurements in mice, which will be utilized by most projects. The
mouse core will also carry out airway dissections that will be utilized by each project. As all projects propose
to utilize a combination of these services, the Mouse Core will be an important part of this Program Project
Grant. The transgenic/knockout production unit is supported by dedicated space within our animal facility
and is fully equipped. In addition, the Holtzman laboratory routinely utilizes the BUXCO system and carries
out isolations of mouse airways, and a technician in his laboratory who is proficient in these techniques will
be the individual doing these experiments for projects in this Program. This core was developed in our
Pulmonary Division in 1995 and has been extensively utilized by Project Investigators, Co-Investigators, and
Core Leaders on this application for many years (Holtzman, Green, Brody, Walter, Shipley). It is staffed by
personnel with a collective extensive track record of expertise and productivity in this area. The core has
been responsible for generating well over 100 separate transgenic and knockout lines, with multiple
founders/chimeras of each. Many of the mice which have been and will be made by this core will further
serve to facilitate collaborative interactions amongst Project Leaders. The Mouse Core is currently also
supported in part by another Program Project Grant (Robert M. Senior, PI) and SCOR grant (Michael J.
Holtzman, PI). The core is also utilized by other investigators at Washington University. Thus, this will allow
us to realize an economy of scales and lower production costs per mouse generated.
National Institute of Allergy and Infectious Diseases
CFDA Code
DUNS Number
068552207
UEI
L6NFUM28LQM5
Project Start Date
01-July-2006
Project End Date
31-July-2011
Budget Start Date
01-July-2006
Budget End Date
31-July-2007
Project Funding Information for 2006
Total Funding
$149,763
Direct Costs
$80,437
Indirect Costs
$69,326
Year
Funding IC
FY Total Cost by IC
2006
National Institute of Allergy and Infectious Diseases
$149,763
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1U19AI070489-01 9003
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1U19AI070489-01 9003
Patents
No Patents information available for 1U19AI070489-01 9003
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1U19AI070489-01 9003
Clinical Studies
No Clinical Studies information available for 1U19AI070489-01 9003
News and More
Related News Releases
No news release information available for 1U19AI070489-01 9003
History
No Historical information available for 1U19AI070489-01 9003
Similar Projects
No Similar Projects information available for 1U19AI070489-01 9003